Key result
MMP-9 and TIMP-1 levels show no clear clinical impact after PCI for acute MI.
Key points are not available for this paper at this time.
Design
Other
Answers are grounded in this paper and cite their sources.
MMP-9 and TIMP-1 levels post-PCI in AMI lack clinical correlation; leaves open their prognostic value pending outcome-linked studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Grachev et al. (2018) studied this question. Matrix metallopeptidase 9 and TIMP-1 levels were analyzed in patients with acute myocardial infarction after percutaneous coronary interventions, though no clinical findings are reported.
Synapse has enriched 10 related papers. Consider them for comparative context: